Calendula officinalis for Health & Longevity - Quick Reference Sheet
evipedia.ai
← Back

Calendula officinalis for Health & Longevity

Created on 09/14/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 5 – Audit

Topical calendula calms inflammation only where it touches. Shallow acute wounds and the surgical cut made during childbirth close faster and hurt less. Vaginal infection, gum inflammation and irritated skin show smaller but real benefit. Use during radiation treatment is the weakest link. Nothing supports a body-wide or life-extending effect. The one recurring harm is permanent daisy-family skin allergy. (Full Review)

Protocol

Standard topical preparation
2–10% ointment or 1–2% cream
Flower extract on clean skin two to three times daily until resolution.
Vaginal preparation
5 g of 1% cream
Inserted by applicator each night for seven consecutive nights.
Oral and mucosal rinse
2 mL tincture in 6 mL water
Rinsed twice daily; or 1–2 g dried florets in 150 mL hot water, gargled two to three times daily.
Time to effect
Wounds and dermatitis
3–8 days
Fast for local endpoints; trials detect differences in this window.
Vaginal courses
7–14 days
Fixed seven-night course, judged at the end of this window.
Gum inflammation
3 months
Detected at three months; no effect accumulates beyond that.

Benefits

Contraindications
  • Known Asteraceae or Compositae allergy (positive patch test to the Compositae mix or sesquiterpene lactone mix)
  • Pregnant women, oral preparations at any trimester
  • Breastfeeding women, oral preparations
  • Deep, penetrating, bite, burn or surgically closed wounds, or a diabetic foot ulcer graded Wagner 2 or above
  • General anaesthesia scheduled within 14 days, oral preparations
  • Infants under 1 month of age, any preparation
    •
Key Interactions
  • Sedative and hypnotic medications: oral use (diazepam)
  • Antihypertensive medications: oral use (amlodipine)
  • Glucose-lowering medications: oral use (metformin)
  • Topical corticosteroids and other topical anti-inflammatories: co-application (hydrocortisone)
  • Over-the-counter sedating antihistamines: oral use (diphenhydramine)
  • Over-the-counter topical antiseptics and keratolytics: same site (povidone-iodine)
  • Sedating supplements: oral use (valerian)
  • Other daisy-family botanicals: topical or oral (chamomile)
  • Supplements with additive effects: oral use (berberine, beetroot nitrate)
  • Radiotherapy: applied after each session, removed before the next
  • Other interventions: laser therapy, compression bandaging, occlusive dressings

Risk & Side Effects

  • Medium: Allergic contact dermatitis; slower early clearance of vaginal infection than standard drug therapy
  • Low: Poor cosmetic acceptability and application difficulty; product variability and contamination in unregulated preparations; masking or delaying treatment of a serious wound
  • Speculative: Liver enzyme changes with prolonged high-dose oral extract; uterine stimulation and pregnancy risk; additive sedation and blood-pressure lowering

Monitoring

Marker Target Why
Wound surface area (planimetry) Steady decline; near-complete closure of shallow acute wounds by 8–10 days Objective proof of the main claimed benefit
Radiation skin toxicity grade Grade 0–1 throughout treatment Detects moderate-or-worse injury
Transepidermal water loss Return to within 10% of the untreated adjacent-site value Tracks barrier recovery, not appearance
Vaginal pH 3.8–4.5 Confirms the vaginal environment normalised
Nugent score 0–3 Microbiological cure, not symptom relief
Gingival Index and Plaque Index Gingival Index below 1.0; Plaque Index below 1.0 Quantifies gum inflammation and plaque
High-sensitivity C-reactive protein Below 1.0 mg/L Only practical check on body-wide effect
Alanine and aspartate aminotransferase Both below 25 U/L Screens the animal hepatic signal during oral use
Compositae mix patch test Negative at 48 and 96 hours Identifies daisy-family allergy before use

Cadence: Baseline; wounds and dermatitis at 1 and 4 weeks; vaginal course at 7 and 30 days; gum indices at 3 and 6 months; radiation grade weekly; application site at 48–72 hours.

Qualitative Assessment

  • Pain at the treated site, scored 0–10 daily, falling within two to three days.
  • Itch or burning appearing after 48 hours, which points to allergy.
  • Ease of application and staining, which govern complete application.
  • Sleep quality and daytime alertness during oral use.
  • Overall comfort and confidence in the treated area.
Not medical advice. Educational distillation of a single evidence review. Confirm any decision with a qualified clinician, especially in the presence of prescription drugs or chronic conditions.